M8168
4-甲基伞形酮磷酸酯 二钠盐
phosphatase substrate, ≥98% (TLC), powder
别名:
4-MUP, 4-甲基伞形磷酸二钠
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C10H7Na2O6P
化学文摘社编号:
分子量:
300.11
NACRES:
NA.32
PubChem Substance ID:
UNSPSC Code:
12352204
EC Number:
245-325-0
MDL number:
产品名称
4-甲基伞形酮磷酸酯 二钠盐,
InChI key
WUUDJQVNZPEPKN-UHFFFAOYSA-L
InChI
1S/C10H9O6P.2Na/c1-6-4-10(11)15-9-5-7(2-3-8(6)9)16-17(12,13)14;;/h2-5H,1H3,(H2,12,13,14);;/q;2*+1/p-2
SMILES string
[Na+].[Na+].CC1=CC(=O)Oc2cc(OP([O-])([O-])=O)ccc12
Quality Level
assay
≥98% (TLC)
form
powder
solubility
water: 50 mg/mL, clear, colorless
fluorescence
λex 319 nm; λem 384 nm (pH 9.0), λex 360 nm; λem 449 nm (Reaction product)
storage temp.
−20°C
相关类别
General description
磷酸酶的荧光底物。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Rubhana Raqib et al.
BMC infectious diseases, 12, 111-111 (2012-05-12)
Treatment of shigellosis in rabbits with butyrate reduces clinical severity and counteracts the downregulation of cathelicidin (CAP-18) in the large intestinal epithelia. Here, we aimed to evaluate whether butyrate can be used as an adjunct to antibiotics in the treatment
Lucia A de Oliveira Fraga et al.
BMC immunology, 11, 56-56 (2010-11-17)
During the pre-patent stage of infection, juvenile Schistosoma blood flukes co-opt signals from the adaptive immune system to facilitate parasite development, but the types of responses that are induced at this early stage of infection, and the parasite antigens they
Ameirika et al.
Toxicon : official journal of the International Society on Toxinology, 133, 153-161 (2017-05-10)
Hydra actinoporin-like toxin-1 (HALT-1) is a 20.8 kDa pore-forming toxin isolated from Hydra magnipapillata. HALT-1 shares structural similarity with actinoporins, a family that is well known for its haemolytic and cytolytic activity. However, the precise pore-forming mechanism of HALT-1 remains an
Giulia Pavani et al.
Nature communications, 11(1), 3778-3778 (2020-07-31)
Targeted genome editing has a great therapeutic potential to treat disorders that require protein replacement therapy. To develop a platform independent of specific patient mutations, therapeutic transgenes can be inserted in a safe and highly transcribed locus to maximize protein
Erica Silberstein et al.
PloS one, 13(4), e0195879-e0195879 (2018-04-20)
Chagas disease, caused by the intracellular protozoan Trypanosoma cruzi, affects 8-10 million people worldwide and represents a major public health challenge. There is no effective treatment or vaccine to control the disease that is characterized by a mild acute phase
相关内容
Product Information Sheet
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持